CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Sibutramine

西布曲明 杂质对照品Sibutramine Impurities

USP31 个杂质条目31 impurity entries

本页汇总 西布曲明 的 31 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 31 impurity reference standards of Sibutramine with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 西布曲明(Sibutramine)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesDevelopment and validation of high performance liquid chromatography method for analysis of sibutramine hydrochloride and its impurity
    Pakistan journal of pharmaceutical sciences · 2008 · Chandorkar JG et al.  ·  PMID 18390441
  2. 杂质研究Impurity studiesDetermination of N-desmethyl- and N-bisdesmethyl metabolites of Sibutramine in doping control analysis using liquid chromatography-tandem mass spectrometry
    European journal of mass spectrometry (Chichester, England) · 2006 · Thevis M et al.  ·  PMID 16723754  ·  DOI
  3. 杂质研究Impurity studiesAn evaluation of the genotoxic and cytotoxic effects of the anti-obesity drugs sibutramine and fenproporex
    Human & experimental toxicology · 2010 · da Silva CJ et al.  ·  PMID 20051455  ·  DOI
  4. 分析方法Analytical MethodsAQbD-based development and validation of an HPLC-PDA method for simultaneous determination of sibutramine, desmethylsibutramine, and didesmethylsibutramine in herbal weight-loss supplements
    RSC advances · 2026 · Minh DTC et al.  ·  PMID 42769694  ·  DOI
  5. 分析方法Analytical MethodsColorimetric and Reverse Fluorescence Dual-Signal Readout Immunochromatographic Assay for the Sensitive Determination of Sibutramine
    ACS omega · 2024 · Gui Y et al.  ·  PMID 38371773  ·  DOI

西布曲明 —— 原料药与杂质对照品Sibutramine — drug substance & impurities

共 31 个条目(含原料药本体)31 items incl. the drug substance
Sibutramine Impurity 23 (Sibutramine USP Related Compound B) structure
USPB
西布曲明杂质23 (西布曲明USP相关化合物B)Sibutramine Impurity 23 (Sibutramine USP Related Compound B)
Sibutramine Impurity 23 (Sibutramine USP Related Compound B)
CAS No.2727060-96-8
Chemical FormulaC17H26ClN·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Sibutramine Impurity 24 (Sibutramine USP Related Compound C) structure
USPC
西布曲明杂质24 (西布曲明USP相关化合物C)Sibutramine Impurity 24 (Sibutramine USP Related Compound C)
Sibutramine Impurity 24 (Sibutramine USP Related Compound C)
CAS No.2727060-94-6
Chemical FormulaC17H26ClN·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Sibutramine Impurity 1 Hydrochloride structure
1
西布曲明杂质1 盐酸盐Sibutramine Impurity 1 Hydrochloride
Sibutramine Impurity 1 Hydrochloride
CAS No.84484-78-6
Chemical FormulaC15H22ClN·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Sibutramine Impurity 2 Monomer structure
2
西布曲明杂质2 单体Sibutramine Impurity 2 Monomer
Sibutramine Impurity 2 Monomer
CAS No.168835-59-4
Chemical FormulaC16H24ClN
Purity>95%询价On request
10mg25mg50mg100mg
Sibutramine Impurity 2 structure
2
西布曲明杂质2Sibutramine Impurity 2
Sibutramine Impurity 2
CAS No.84467-94-7
Chemical FormulaC16H25Cl2N
Purity>95%询价On request
10mg25mg50mg100mg
Sibutramine Impurity 3 structure
3
西布曲明杂质3Sibutramine Impurity 3
Sibutramine Impurity 3
CAS No.84467-85-6
Chemical FormulaC16H22ClNO
Purity>95%询价On request
10mg25mg50mg100mg
Sibutramine Impurity 4 structure
4
西布曲明杂质4Sibutramine Impurity 4
Sibutramine Impurity 4
CAS No.153341-23-2
Chemical FormulaC17H26ClN·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Sibutramine Impurity 5 structure
5
西布曲明杂质5Sibutramine Impurity 5
Sibutramine Impurity 5
CAS No.154752-45-1
Chemical FormulaC17H26ClN·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Sibutramine Impurity 6 structure
6
西布曲明杂质6Sibutramine Impurity 6
Sibutramine Impurity 6
CAS No.259731-39-0
Chemical FormulaC16H24ClN·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Sibutramine Impurity 7 structure
7
西布曲明杂质7Sibutramine Impurity 7
Sibutramine Impurity 7
CAS No.259731-40-3
Chemical FormulaC16H24ClN·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Sibutramine Impurity 8 structure
8
西布曲明杂质8Sibutramine Impurity 8
Sibutramine Impurity 8
CAS No.262854-36-4
Chemical FormulaC15H22ClN·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Sibutramine Impurity 9 structure
9
西布曲明杂质9Sibutramine Impurity 9
Sibutramine Impurity 9
CAS No.262854-35-3
Chemical FormulaC15H22ClN·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Sibutramine Impurity 10 Monomer structure
10
西布曲明杂质10 单体Sibutramine Impurity 10 Monomer
Sibutramine Impurity 10 Monomer
CAS No.766462-77-5
Chemical FormulaC17H25Cl2N
Purity>95%询价On request
10mg25mg50mg100mg
Sibutramine Impurity 10 structure
10
西布曲明杂质10Sibutramine Impurity 10
Sibutramine Impurity 10
CAS No.84485-08-5
Chemical FormulaC17H25Cl2N·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Sibutramine Impurity 12 structure
12
西布曲明杂质12Sibutramine Impurity 12
Sibutramine Impurity 12
CAS No.84484-93-5
Chemical FormulaC14H20ClN·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Sibutramine Impurity 13 structure
13
西布曲明杂质13Sibutramine Impurity 13
Sibutramine Impurity 13
CAS No.844882-77-5
Chemical FormulaC18H28ClN
Purity>95%询价On request
10mg25mg50mg100mg
Sibutramine Impurity 14 structure
14
西布曲明杂质14Sibutramine Impurity 14
Sibutramine Impurity 14
CAS No.28049-61-8
Chemical FormulaC11H10ClN
Purity>95%询价On request
10mg25mg50mg100mg
Sibutramine Impurity 15 structure
15
西布曲明杂质15Sibutramine Impurity 15
Sibutramine Impurity 15
CAS No.3058304-40-5
Chemical FormulaC18H27Cl2N
Purity>95%询价On request
10mg25mg50mg100mg
Sibutramine Impurity 1-d7 structure
1-D7
西布曲明杂质1-d7Sibutramine Impurity 1-d7
Sibutramine Impurity 1-d7
CAS No.1188263-87-7
Chemical FormulaC15H15D7ClN·HCl
Purity>95%询价On request
Sibutramine Impurity 17 structure
17
西布曲明杂质17Sibutramine Impurity 17
Sibutramine Impurity 17
CAS No.59242-93-2
Chemical FormulaC14H14ClN
Purity>95%询价On request
10mg25mg50mg100mg
Sibutramine Impurity 18 structure
18
西布曲明杂质18Sibutramine Impurity 18
Sibutramine Impurity 18
CAS No.84467-55-0
Chemical FormulaC17H27N
Purity>95%询价On request
10mg25mg50mg100mg
Sibutramine Impurity 18 Hydrochloride structure
18
西布曲明杂质18 盐酸盐Sibutramine Impurity 18 Hydrochloride
Sibutramine Impurity 18 Hydrochloride
CAS No.84485-01-8
Chemical FormulaC17H27N·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Sibutramine Impurity 19 structure
19
西布曲明杂质19Sibutramine Impurity 19
Sibutramine Impurity 19
CAS No.186521-85-7
Chemical FormulaC15H19ClO
Purity>95%询价On request
10mg25mg50mg100mg
Sibutramine Impurity 20 structure
20
西布曲明杂质20Sibutramine Impurity 20
Sibutramine Impurity 20
CAS No.2724727-21-1
Chemical FormulaC15H21ClO
Purity>95%询价On request
10mg25mg50mg100mg
Sibutramine Impurity 21 structure
21
西布曲明杂质21Sibutramine Impurity 21
Sibutramine Impurity 21
CAS No.69850-52-8
Chemical FormulaC17H24BrN·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Sibutramine Impurity 22 structure
22
西布曲明杂质22Sibutramine Impurity 22
Sibutramine Impurity 22
CAS No.2724727-26-6
Chemical FormulaC17H26ClN·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Sibutramine Impurity 25 structure
25
西布曲明杂质25Sibutramine Impurity 25
Sibutramine Impurity 25
CAS No.2758418-79-8
Chemical FormulaC16H23Cl2N
Purity>95%询价On request
10mg25mg50mg100mg
Sibutramine Impurity 2-d6 structure
2-D6
西布曲明杂质2-d6Sibutramine Impurity 2-d6
Sibutramine Impurity 2-d6
CAS No.1189935-32-7
Chemical FormulaC16H18D6ClN·HCl
Purity>95%询价On request
Sibutramine Impurity 26 structure
26
西布曲明杂质26Sibutramine Impurity 26
Sibutramine Impurity 26
CAS No.2518198-73-5
Chemical FormulaC13H18ClN
Purity>95%询价On request
10mg25mg50mg100mg
Sibutramine Impurity 26 Hydrochloride structure
26
西布曲明杂质26 盐酸盐Sibutramine Impurity 26 Hydrochloride
Sibutramine Impurity 26 Hydrochloride
CAS No.2518198-74-6
Chemical FormulaC13H18ClN·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Sibutramine Impurity 2-d7 structure
2-D7
西布曲明杂质2-d7Sibutramine Impurity 2-d7
Sibutramine Impurity 2-d7
CAS No.1188265-54-4
Chemical FormulaC16H17D7ClN·HCl
Purity>95%询价On request

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

西布曲明 —— 研究文献与合成路线Sibutramine — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 西布曲明 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Sibutramine. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Development and validation of high performance liquid chromatography method for analysis of sibutramine hydrochloride and its impurity
    Chandorkar JG, Kotwal VB, Dhande NS, et al. · Pakistan journal of pharmaceutical sciences · 2008 · 被引 2cited 2
  2. LC method for the determination of assay and purity of sibutramine hydrochloride and its enantiomers by chiral chromatography
    Radhakrishna T, Narayana CL, Rao DS, et al. · Journal of pharmaceutical and biomedical analysis · 2000 · 被引 14cited 14
  3. Colorimetric and Reverse Fluorescence Dual-Signal Readout Immunochromatographic Assay for the Sensitive Determination of Sibutramine
    Gui Y, Zhao Y, Liu P, et al. · ACS omega · 2024 · 被引 4cited 4

合成与制备工艺专利Synthesis & process patents

  1. Preparation of monoclonal antibody of specific combined sibutramine and demethylated sibutramine
    YANG XU, JIEBIAO GUO, QINGHUA HE, YANPING LI, et al. · 公开号 CN101643506CN101643506 · 2010
  2. Optically pure Sibutramine and process for preparing salt derivative thereof
    YU HU, XIAOXIA SUN, YING GUO, ZHIZHEN ZHOU, et al. · 公开号 CN101514163CN101514163 · 2009
  3. (R)-SIBUTRAMINE SALTS AND THE PREPARATION THEREOF
    MIN YUN SIK, LEE HYUNG CHOUL · 公开号 WO2010087544WO2010087544 · 2010
  4. CRYSTALLINE SIBUTRAMINE FREE BASE AND PROCESS FOR PREPARING IT
    MIN YUN SIK · 公开号 KR20070121991KR20070121991 · 2007
  5. A NOVEL SIBUTRAMINE ORGANIC ACID SALT AND MANUFACTURING PROCESS THEREOF
    KANG JAE HOON, LEE SEOK JOON, KIM JUNG MIN, LEE SANG YOUNG · 公开号 KR100857342BKR100857342B · 2008

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

西布曲明 杂质谱研究要点Sibutramine — impurity profiling notes

下面这些是拿到 西布曲明 的 31 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 31 impurity entries for Sibutramine, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances